Detailed definition
Progestins are synthetic compounds that bind the progesterone receptor and produce progestational effects. They are structurally related to progesterone but differ in pharmacology — most progestins also have varying degrees of androgenic, estrogenic, antiandrogenic, or glucocorticoid activity. Common progestins in HRT include: medroxyprogesterone acetate (Provera), norethindrone (norethisterone), drospirenone, and levonorgestrel. The 52-mg levonorgestrel-releasing IUD (Mirena) provides endometrial protection in women on estrogen with a uterus and is a particularly well-tolerated option for women who do not want a daily progestogen. Observational data — including the French E3N study — suggest that synthetic progestins (notably medroxyprogesterone) carry a higher breast cancer signal than bioidentical micronized progesterone over 5+ years of use, contributing to the modern preference for micronized progesterone in HRT.
Why it matters in menopause
For women with a uterus on systemic estrogen, the choice of progestogen matters. Bioidentical micronized progesterone is generally preferred. Synthetic progestins remain useful in specific contexts (combined patches, IUDs, women who tolerate a particular progestin well).
Related terms
Sources
External references: Wikipedia.